These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2563798)

  • 21. Intraperitoneal erythropoietin in children on peritoneal dialysis: A study of pharmacokinetics and efficacy.
    Kausz AT; Watkins SL; Hansen C; Godwin DA; Palmer RB; Brandt JR
    Am J Kidney Dis; 1999 Oct; 34(4):651-6. PubMed ID: 10516345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Lui SF; Leung JC; Law E; Nicholls MG
    Nephron; 1991; 57(4):394-400. PubMed ID: 1828543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of subcutaneous recombinant human erythropoietin (r-Hu EPO) in CAPD patients with renal anaemia.
    Janicka L; Ksiazek A; Baranowicz I; Mierzicki P
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():67-77. PubMed ID: 8192534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction of anemia using self-administered daily subcutaneous erythropoietin in uremic patients on continuous ambulatory peritoneal dialysis.
    Li PK; Leung CB; Lui SF; Leung JC; Shek AC; Lai KN
    Int J Artif Organs; 1993 Jul; 16(7):510-4. PubMed ID: 8370605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose subcutaneous erythropoietin in continuous ambulatory peritoneal dialysis.
    Rotellar C; Mazzoni MJ; Mosher WF; Aminrazavi M; Bauer A; Rakowski TA; Schreiner GE; Winchester JF
    Am J Hematol; 1991 May; 37(1):31-3. PubMed ID: 2024637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of the anemia with human recombinant erythropoietin in CAPD patients.
    Miranda B; Selgas R; Riñon C; Fernandez-Zamorano A; Borrego F; Ortuño F; Lopez-Revuelta K; Torre A; Sanchez Sicilia L
    Adv Perit Dial; 1990; 6():296-301. PubMed ID: 1982831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of erythropoietin determination in the dialysate of CAPD patients.
    Struijk DG; Koomen GC; Krediet RT; Arisz L
    Adv Perit Dial; 1990; 6():289-91. PubMed ID: 1982829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M; Bartlett DK; Brier ME; Golper TA
    Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of erythropoietin following single-dose subcutaneous administration in preterm infants.
    Krishnan R; Shankaran S; Krishnan M; Kauffman RE; Kumar P; Lucena J
    Biol Neonate; 1996; 70(3):135-40. PubMed ID: 8894079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routes of administration of r-HuEPO in CAPD.
    Boelaert JR; Schurgers ML; Matthys EG; Daneels RF
    Nephrol Dial Transplant; 1989; 4(7):676. PubMed ID: 2510072
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum erythropoietin levels in hemodialysed patients after administration of recombinant human erythropoietin.
    Pavlović-Kentera V; Clemons GK; Biljanović-Paunović L; Marisavljević D; Lezaić V; Pokrajac M; Djukanović L
    Biomed Pharmacother; 1992; 46(1):37-43. PubMed ID: 1421034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the pharmacokinetics of human recombinant erythropoietin in blood and brain when administered immediately after lateral fluid percussion brain injury and its pharmacodynamic effects on IL-1beta and MIP-2 in rats.
    Lieutaud T; Andrews PJ; Rhodes JK; Williamson R
    J Neurotrauma; 2008 Oct; 25(10):1179-85. PubMed ID: 18842103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin.
    Xenocostas A; Cheung WK; Farrell F; Zakszewski C; Kelley M; Lutynski A; Crump M; Lipton JH; Kiss TL; Lau CY; Messner HA
    Eur J Clin Pharmacol; 2005 May; 61(3):189-95. PubMed ID: 15776276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin and peritoneal dialysis: the efficacy of intraperitoneal dosing.
    Nissenson AR
    Perit Dial Int; 1992; 12(4):350-2. PubMed ID: 1420491
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution.
    Ohls RK; Veerman MW; Christensen RD
    J Pediatr; 1996 Apr; 128(4):518-23. PubMed ID: 8618186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics of epoetin (recombinant human erythropoietin).
    Macdougall IC; Roberts DE; Coles GA; Williams JD
    Clin Pharmacokinet; 1991 Feb; 20(2):99-113. PubMed ID: 2029809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis].
    Zelichowski G; Lubas A; Sienkiewicz M; Janusz E; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):312-5. PubMed ID: 18634362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medium term response to H-R erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels and the effects on peritoneal transport capacity.
    Bajo MA; Selgas R; Miranda B; Fernandez-Zamorano A; Borrego F; Romero JR; Caparros G; Riñon C; Sanchez Sicilia L
    Adv Perit Dial; 1991; 7():296-300. PubMed ID: 1680450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers.
    McMahon FG; Vargas R; Ryan M; Jain AK; Abels RI; Perry B; Smith IL
    Blood; 1990 Nov; 76(9):1718-22. PubMed ID: 2224121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horses.
    Souillard A; Audran M; Bressolle F; Jaussaud P; Gareau R
    Biopharm Drug Dispos; 1996 Dec; 17(9):805-15. PubMed ID: 8968532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.